Gainers
- Epizyme EPZM stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6 million shares, making up 418.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $149.0 million.
- Pharming PHAR shares rose 11.65% to $9.85. Trading volume for Pharming's stock is 54.4K as of 12:30 EST. This is 536.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $628.9 million.
- Exicure XCUR shares increased by 10.66% to $0.23. Trading volume for this security as of 12:30 EST is 16.7 million, which is 263.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.2 million.
- Entasis Therapeutics Hldg ETTX shares moved upwards by 10.37% to $1.6. The current volume of 7.4 million shares is 5410.2% of Entasis Therapeutics Hldg's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $76.2 million.
- Nanobiotix NBTX stock rose 9.13% to $8.72. The company's market cap stands at $303.5 million.
- Cyclacel Pharmaceuticals CYCCP stock increased by 8.15% to $6.76.
Losers
- LogicBio Therapeutics LOGC stock decreased by 55.2% to $0.67 during Wednesday's regular session. LogicBio Therapeutics's stock is trading at a volume of 3.4 million shares as of 12:30 EST. This is 3512.1% of its average full-day volume over the last 100 days. The company's market cap stands at $22.1 million.
- Xilio Therapeutics XLO stock declined by 15.33% to $10.72. The company's market cap stands at $294.4 million.
- Immix Biopharma IMMX stock decreased by 14.11% to $3.96. Trading volume for this security as of 12:30 EST is 966.5K, which is 8.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.9 million.
- NeuBase Therapeutics NBSE shares fell 14.03% to $1.48. As of 12:30 EST, this security is trading at a volume of 115.7K shares, making up 71.6% of its average full-day volume over the last 100 days. The company's market cap stands at $48.3 million.
- Dermata Therapeutics DRMA shares fell 13.18% to $2.07. The market value of their outstanding shares is at $17.2 million.
- GBS GBS shares declined by 12.89% to $0.89. Trading volume for GBS's stock is 153.9K as of 12:30 EST. This is 15.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in